Literature DB >> 26226433

The Chinese Version of the Gotland Male Depression Scale (GMDS): Mokken scaling.

Chin-Pang Lee1, Chun-Lin Chu2, Yu Chen3, Kun-Hao Jiang4, Jiun-Liang Chen4, Ching-Yen Chen5.   

Abstract

OBJECTIVE: Invariant item ordering (IIO) is defined as the extent to which items have the same order for each respondent who completes a scale. IIO is crucial for establishing a scale hierarchy that is replicable across samples; however, no research has demonstrated IIO in the Gotland Male Depression Scale (GMDS). The aim of this study was to determine if an IIO hierarchy of depressive symptoms existed in a clinical sample of men who completed the GMDS.
METHODS: A convenience sample of 231 men (age: mean (SD) = 46.1 (11.0) yrs) who visited a men's health polyclinic in Taiwan and completed the GMDS. Mokken scale analysis was conducted to evaluate the psychometric properties of the GMDS.
RESULTS: All items on the GMDS formed a strong uni-dimensional scale (H=0.592). Except for item #9 (alcohol/drug abuse, or hyperactivity), IIO was found for the remaining 12 items (H(T)=0.366). These symptoms reflected the following hierarchy: positive family history (#13), complaining (#12), anxiety (#8), loss of vitality (#10), depressed mood (#11), indecisiveness (#6), aggression (#2), irritability (#5), stress (#1), burn-out (#3), fatigue (#4), and sleep problems (#7).
CONCLUSION: The GMDS is a psychometrically sound measure of depressive symptoms in Taiwanese male outpatients. The GMDS has both cumulative and hierarchical properties.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gotland Male Depression Scale; Item ordering; Item response theory; Men; Mokken scale analysis

Mesh:

Year:  2015        PMID: 26226433     DOI: 10.1016/j.jad.2015.06.045

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  1 in total

1.  Construct validity of the Depression and Somatic Symptoms Scale: evaluation by Mokken scale analysis.

Authors:  Ya-Hsin Chou; Chin-Pang Lee; Chia-Yih Liu; Ching-I Hung
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-23       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.